Penile Carcinoma — Trials

Penile Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

44 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07808359	Amivantamab in Patients With Metastatic/Recurrent Penile Squamous Cell Carcinoma(APOLO)	not yet recruiting	Phase 2	58	Latin American Cooperative Oncology GroupOTHER	1	Sep 14, 2026	clinicaltrials
NCT07815197	Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer(PERSEUS)	not yet recruiting	Phase 2	37	Latin American Cooperative Oncology GroupOTHER	1